ATE37358T1 - 1,3-disubstituierte piperidinverbindungen als neuroleptische mittel. - Google Patents
1,3-disubstituierte piperidinverbindungen als neuroleptische mittel.Info
- Publication number
- ATE37358T1 ATE37358T1 AT85305079T AT85305079T ATE37358T1 AT E37358 T1 ATE37358 T1 AT E37358T1 AT 85305079 T AT85305079 T AT 85305079T AT 85305079 T AT85305079 T AT 85305079T AT E37358 T1 ATE37358 T1 AT E37358T1
- Authority
- AT
- Austria
- Prior art keywords
- piperidine compounds
- neuroleptic agents
- useful
- formula
- fluoro
- Prior art date
Links
- 239000003176 neuroleptic agent Substances 0.000 title abstract 3
- -1 1,3-DISUBSTITUTED PIPERIDINE COMPOUNDS Chemical class 0.000 title abstract 2
- 208000028017 Psychotic disease Diseases 0.000 abstract 2
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 2
- 125000001153 fluoro group Chemical group F* 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- LXCUAFVVTHZALS-UHFFFAOYSA-N 3-(3-methoxyphenyl)piperidine Chemical class COC1=CC=CC(C2CNCCC2)=C1 LXCUAFVVTHZALS-UHFFFAOYSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010014557 Emotional poverty Diseases 0.000 abstract 1
- 206010041243 Social avoidant behaviour Diseases 0.000 abstract 1
- 230000016571 aggressive behavior Effects 0.000 abstract 1
- 238000013019 agitation Methods 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/634,910 US4593037A (en) | 1984-07-26 | 1984-07-26 | 1,3-disubstituted piperidine compounds as neuroleptic agents |
EP85305079A EP0175452B1 (en) | 1984-07-26 | 1985-07-17 | 1,3-disubstituted piperidine compounds as neuroleptic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE37358T1 true ATE37358T1 (de) | 1988-10-15 |
Family
ID=24545655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT85305079T ATE37358T1 (de) | 1984-07-26 | 1985-07-17 | 1,3-disubstituierte piperidinverbindungen als neuroleptische mittel. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4593037A (en, 2012) |
EP (1) | EP0175452B1 (en, 2012) |
JP (1) | JPS6137768A (en, 2012) |
AT (1) | ATE37358T1 (en, 2012) |
DE (1) | DE3565102D1 (en, 2012) |
DK (1) | DK167974B1 (en, 2012) |
GR (1) | GR851811B (en, 2012) |
IE (1) | IE58121B1 (en, 2012) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0299549A3 (en) * | 1987-07-09 | 1989-02-08 | Duphar International Research B.V | Tertiary 2,5-dialkyl-3-phenyl-piperidine derivatives having opiate-antagonistic activity |
US5153206A (en) * | 1988-12-02 | 1992-10-06 | Pfizer Inc. | Arylpiperidine derivatives |
US5109002A (en) * | 1989-09-08 | 1992-04-28 | Du Pont Merck Pharmaceutical Company | Antipsychotic 1-cycloalkylpiperidines |
US5459151A (en) * | 1993-04-30 | 1995-10-17 | American Home Products Corporation | N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents |
US5457207A (en) * | 1993-10-05 | 1995-10-10 | Regents Of The University Of Minnesota | Spirovesamicols |
DE102004036349A1 (de) * | 2004-07-27 | 2006-03-23 | Grünenthal GmbH | Substituierte 3-Phenylpiperidin-Derivate |
HK1215170A1 (zh) | 2012-11-14 | 2016-08-19 | The Johns Hopkins University | 治療精神分裂症的方法和組合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB984119A (en) * | 1960-06-20 | 1965-02-24 | Aspro Nicholas Ltd | Substituted piperidines and methods for their preparation |
GB1044309A (en) * | 1964-05-07 | 1966-09-28 | Koninklijke Pharma Fab Nv | Substituted 1-aralklyl-piperidines |
FR2310762A1 (fr) * | 1975-05-16 | 1976-12-10 | Roussel Uclaf | Nouveaux derives n-substitues de la phenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments |
US4241071A (en) * | 1977-01-27 | 1980-12-23 | American Hoechst Corporation | Antidepressant (α-phenyl-2-tolyl)azacycloalkanes |
US4332942A (en) * | 1977-09-13 | 1982-06-01 | Pfizer, Inc. | 3-(2-Hydroxy-4-(substituted)phenyl)azacycloalkanes as analgesics |
GR72841B (en, 2012) * | 1979-12-05 | 1983-12-07 | Carlsson Arvid Emil |
-
1984
- 1984-07-26 US US06/634,910 patent/US4593037A/en not_active Expired - Fee Related
-
1985
- 1985-07-17 EP EP85305079A patent/EP0175452B1/en not_active Expired
- 1985-07-17 DE DE8585305079T patent/DE3565102D1/de not_active Expired
- 1985-07-17 AT AT85305079T patent/ATE37358T1/de not_active IP Right Cessation
- 1985-07-22 GR GR851811A patent/GR851811B/el unknown
- 1985-07-22 JP JP60160402A patent/JPS6137768A/ja active Granted
- 1985-07-24 IE IE185785A patent/IE58121B1/en not_active IP Right Cessation
- 1985-07-25 DK DK338985A patent/DK167974B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0175452A1 (en) | 1986-03-26 |
DK167974B1 (da) | 1994-01-10 |
DK338985A (da) | 1986-03-13 |
IE851857L (en) | 1986-01-26 |
US4593037A (en) | 1986-06-03 |
GR851811B (en, 2012) | 1985-11-26 |
DK338985D0 (da) | 1985-07-25 |
IE58121B1 (en) | 1993-07-14 |
JPH0533696B2 (en, 2012) | 1993-05-20 |
JPS6137768A (ja) | 1986-02-22 |
DE3565102D1 (en) | 1988-10-27 |
EP0175452B1 (en) | 1988-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900700486A (ko) | 신규한 벤조피리도 피페리딘, 피페리딜리덴 및 피페라진 화합물, 조성물, 제조방법 및 이용방법 | |
ATE65500T1 (de) | Arylthioalkylphenylcarbonsaeuren, diese enthaltende zusammensetzungen und deren verwendung. | |
YU66895A (sh) | Nova heterociklična jedinjenja, postupci za njihovo dibijanje i primena tih novih jedinjenja | |
FR2677019B1 (fr) | Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique. | |
FR2692264B1 (fr) | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. | |
PT77886B (fr) | Naphtalene et azanaphtalenecarboxamide medicaments | |
ATE37358T1 (de) | 1,3-disubstituierte piperidinverbindungen als neuroleptische mittel. | |
DE3855325D1 (de) | Oxothiolane und Derivate, diese enthaltende pharmazeutische Zubereitungen und ihre Verwendung als Arzneimittel | |
NO871059L (no) | Nye carboxylsyrederivater, fremgangsmaate for fremstilling av disse, anvendelse derav, saa vel som legemidler inneholdende disse forbindelser. | |
SE8503207D0 (sv) | Pharmacologically active substituted benzamides | |
NO962855L (no) | Nye piperidin-derivater med PAF-antagonist-aktivitet | |
DK163287D0 (da) | 1,4-diazepiner og farmaceutiske midler med indhold af saadanne forbindelser | |
DE69130497D1 (de) | Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis | |
ATE62686T1 (de) | Neue 3-oxadiazol- und 3-carbonsaeure-betacarbolinderivate, ihre herstellung und ihre verwendung als arzneimittel. | |
TR199902350T2 (xx) | Yeni piridin t�revleri ve onlardan olu�an farmakotik bile�imler. | |
KR890006621A (ko) | 항불안제 | |
SE8500107D0 (sv) | Neue 8alfa-acylaminoergoline | |
DE69525633D1 (de) | Chinoxalinderivate und ihre therapeutische verwendbarkeit | |
ATE62908T1 (de) | Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung. | |
NO923004D0 (no) | 6-oxo-azepinoindolforbindelser, saavel som fremgangsmaater og mellomprodukter for fremstilling av disse, og legemidler inneholdende disse forbindelser | |
DE3579682D1 (de) | Tetrazolylderivate und ihre pharmazeutische verwendung. | |
DE68918402D1 (de) | 1,2,3,4-Tetrahydro-1,9-Acridindiamine, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente. | |
ATE40554T1 (de) | Furo(3,2-c>pyridinderivate, ihre herstellung und ihre therapeutische verwendung. | |
NO941084L (no) | Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner | |
MXPA03011193A (es) | Nuevos compuestos utiles en enfermedad de reflujo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |